The Glassware Core and its 24 staff members employ over 100 pieces of equipment, throughout theRockefeller, Schwartz and Zuckerman Research Centers, to deliver more than 5,000 pieces of cleaned andsterilized labware to more than 110 investigators and their staff. Daily routines include decontamination andcollection of soiled labware; hand-scrubbing and visual inspection of each piece before further processing incommercial glasswashers; sorting, wrapping, and/or plugging followed by processing in high-temperatureovens and steam autoclaves before return to the laboratories. Specialized procedures also provide for acidwashingand RNase-free preparations.All processing follows standardized operating procedures specially adapted to meet the needs of each user,and is ascertained to meet the minimum standard of 'visually clean' or less than 4 ug/ml of debris, followingthe criteria for acceptance of LeBlanc and the FDA on the validation of cleaning processes. Over 90% of allwork is restocked in each laboratory within an 8-hour time frame, providing cost and space savings to thelaboratories. This core also provides dry ice stores throughout the research environment, assists with themonitoring of disposal of biohazardous waste and broken glass from laboratories, as well as provides for thedecontamination of radioactive and other forms of biohazardous waste. To minimize costs to thelaboratories, only 'hands-on' time is charged for all services.Changes are anticipated in operating procedures to allow increased standardization in washing with the useof acid and alkaline detergents in the glasswashing machines, further reducing the 'hands-on' time chargedto users. When demand dictates, services will be expanded to include standardized cleaning of specializedlaboratory equipment, such as cell and tissue incubators or freezers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-43
Application #
7671804
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-31
Project End
2012-12-31
Budget Start
2008-07-31
Budget End
2008-12-31
Support Year
43
Fiscal Year
2008
Total Cost
$545,444
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Hu, Zishuo I; Shia, Jinru; Stadler, Zsofia K et al. (2018) Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Clin Cancer Res 24:1326-1336
Connors, Joseph M; Jurczak, Wojciech; Straus, David J et al. (2018) Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. N Engl J Med 378:331-344
Reznik, Ed; Luna, Augustin; Aksoy, Bülent Arman et al. (2018) A Landscape of Metabolic Variation across Tumor Types. Cell Syst 6:301-313.e3
Barbetta, Arianna; Hsu, Meier; Tan, Kay See et al. (2018) Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 155:2710-2721.e3
Feldman, Darren R; Ardeshir-Rouhani-Fard, Shirin; Monahan, Patrick et al. (2018) Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score. Clin Genitourin Cancer 16:e761-e769
Shumway, Dean A; McLeod, Chandler M; Morrow, Monica et al. (2018) Patient Experiences and Clinician Views on the Role of Radiation Therapy for Ductal Carcinoma In Situ. Int J Radiat Oncol Biol Phys 100:1237-1245
García Nores, Gabriela D; Ly, Catherine L; Cuzzone, Daniel A et al. (2018) CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun 9:1970
Morris, Patrick G; Rota, Selene; Cadoo, Karen et al. (2018) Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer. Clin Breast Cancer 18:387-394
McMurry, Timothy L; Stukenborg, George J; Kessler, Larry G et al. (2018) More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study. Ann Surg 268:632-639
Floros, Konstantinos V; Lochmann, Timothy L; Hu, Bin et al. (2018) Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. Proc Natl Acad Sci U S A 115:E2594-E2603

Showing the most recent 10 out of 8799 publications